These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 1098542)

  • 1. [A comparison of the serological effects of classical cholera vaccine and of purified fraction vaccine, with or without simultaneous yellow fever vaccine (author's transl)].
    Gateff C; Dodin A; Wiart J
    Ann Microbiol (Paris); 1975; 126(2):231-46. PubMed ID: 1098542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The inhibiting effect of anticholera vaccination carried out simultaneously or at short intervals on yellow fever immunization. Is it real or assumed? Results of a retrospective study].
    Poveda JD; Raccurt CP; Le Fur R; M'Bailara L; Malvy JM; Le Bras M; Saliou P; Fleury HJ
    Bull Soc Pathol Exot; 1990; 83(4):529-35; discussion 535-6. PubMed ID: 2286006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.
    Adu FD; Adeniji JA; Tomori O; Adelasoye A
    Rev Roum Virol; 1993; 44(1-2):3-7. PubMed ID: 8043476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A serological survey for cholera antibodies in rural east Pakistan. 2. A comparison of antibody titres in the innunized and control populationd of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate.
    Mosley WH; Benenson AS; Barui R
    Bull World Health Organ; 1968; 38(3):335-46. PubMed ID: 5302923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.
    Adu FD; Adeniji JA; Tomori O; Adelasoye A
    Rom J Virol; 1993; 44(1-2):3-7. PubMed ID: 9702244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population--the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cholerae.
    Mosley WH; McCormack WM; Ahmed A; Chowdhury AK; Barui RK
    Bull World Health Organ; 1969; 40(2):187-97. PubMed ID: 5306539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of immune globulin on the response to trivalent oral poliovirus and yellow fever vaccinations.
    Kaplan JE; Nelson DB; Schonberger LB; Hatch MH; Monath TP; Lazuick JS; Calisher CH; Rosa FW
    Bull World Health Organ; 1984; 62(4):585-90. PubMed ID: 6333295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 3. The lack of effect of prior vaccination or circulating vibriocidal antibody on the severity of clinical cholera.
    McCormack WM; Rahman AS; Chowdhury AK; Mosley WH; Phillips RA
    Bull World Health Organ; 1969; 40(2):199-204. PubMed ID: 5306540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The combined measles-yellow fever vaccination in African infants aged 6 to 10 months].
    Mouchon D; Pignon D; Vicens R; Tu-Ha-Thanh ; Tekaia F; Teulières L; Garrigue G
    Bull Soc Pathol Exot; 1990; 83(4):537-51. PubMed ID: 2286007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous administration of hepatitis B and yellow fever vaccines.
    Yvonnet B; Coursaget P; Deubel V; Diop-Mar I; Digoutte JP; Chiron JP
    Dev Biol Stand; 1986; 65():205-7. PubMed ID: 2951287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new combined vaccine against yellow fever and measles in infants aged 6 to 24 months in Mali].
    Soula G; Sylla A; Pichard E; Kodio B; Bentejac MC; Teulières L; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):885-97. PubMed ID: 1819436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
    Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B
    Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological response to cholera revaccination in a semi-closed community in Calcutta.
    Sinha R; Deb BC; Ganguly R; De SP; Abou-Gareeb AH; Shrivastava DL
    Bull World Health Organ; 1970; 43(3):407-12. PubMed ID: 5312995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
    Barrett AD; Teuwen DE
    Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of yellow fever vaccine in children less thanone-year-old.
    Osinusi K; Akinkugbe FM; Akinwolere OA; Fabiyi A
    West Afr J Med; 1990; 9(3):200-3. PubMed ID: 2271433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru.
    Belmusto-Worn VE; Sanchez JL; McCarthy K; Nichols R; Bautista CT; Magill AJ; Pastor-Cauna G; Echevarria C; Laguna-Torres VA; Samame BK; Baldeon ME; Burans JP; Olson JG; Bedford P; Kitchener S; Monath TP
    Am J Trop Med Hyg; 2005 Feb; 72(2):189-97. PubMed ID: 15741556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.